Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ghrelin and resistance training in frail elderly
NCT01898611Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Jul 2013
- Primary completion
- Aug 2016
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of human ghrelin in frailty syndrome, sponsored by University of Pennsylvania. Primary endpoint: Short Physical Performance Battery at 12 weeks. Started Jul 2013; status: completed.
02
Drugs
human ghrelin
03
Conditions
frailty syndrome
Beyond the preview
Go deeper on NCT01898611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01898611.